These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 23875313)
1. In vitro characterization of gastrointestinal behavior of Butyricicoccus pullicaecorum, a novel butyrate producing isolate with probiotic potential to counterbalance dysbiosis in inflammatory bowel disease. Geirnaert A; Steyaert A; Van den Abbeele P; Eeckhaut V; Van Immerseel F; Boon N; Van de Wiele T Commun Agric Appl Biol Sci; 2013; 78(1):157-63. PubMed ID: 23875313 [No Abstract] [Full Text] [Related]
2. In vitro evaluation of the upper gastrointestinal passage of a novel butyrate producing isolate to counterbalance dysbiosis in inflammatory bowel disease. Geirnaert A; Debruyne B; Eeckhaut V; Van Immerseel F; Booni N; Van de Wiele T Commun Agric Appl Biol Sci; 2012; 77(1):45-9. PubMed ID: 22558754 [No Abstract] [Full Text] [Related]
3. In vitro evaluation of the upper gastrointestinal passage of a novel butyrate producing isolate to counterbalance dysbiosis in inflammatory bowel disease. Geirnaert A; Debruyne B; Eeckhaut V; Van Immerseel F; Boon N; Van de Wiele T Commun Agric Appl Biol Sci; 2012; 77(1):195-9. PubMed ID: 22558780 [No Abstract] [Full Text] [Related]
4. Interindividual differences in response to treatment with butyrate-producing Butyricicoccus pullicaecorum 25-3T studied in an in vitro gut model. Geirnaert A; Wang J; Tinck M; Steyaert A; Van den Abbeele P; Eeckhaut V; Vilchez-Vargas R; Falony G; Laukens D; De Vos M; Van Immerseel F; Raes J; Boon N; Van de Wiele T FEMS Microbiol Ecol; 2015 Jun; 91(6):. PubMed ID: 25999470 [TBL] [Abstract][Full Text] [Related]
5. Butyricicoccus pullicaecorum, a butyrate producer with probiotic potential, is intrinsically tolerant to stomach and small intestine conditions. Geirnaert A; Steyaert A; Eeckhaut V; Debruyne B; Arends JB; Van Immerseel F; Boon N; Van de Wiele T Anaerobe; 2014 Dec; 30():70-4. PubMed ID: 25179909 [TBL] [Abstract][Full Text] [Related]
6. Safety assessment of the butyrate-producing Butyricicoccus pullicaecorum strain 25-3(T), a potential probiotic for patients with inflammatory bowel disease, based on oral toxicity tests and whole genome sequencing. Steppe M; Van Nieuwerburgh F; Vercauteren G; Boyen F; Eeckhaut V; Deforce D; Haesebrouck F; Ducatelle R; Van Immerseel F Food Chem Toxicol; 2014 Oct; 72():129-37. PubMed ID: 25007784 [TBL] [Abstract][Full Text] [Related]
7. Butyricicoccus pullicaecorum gen. nov., sp. nov., an anaerobic, butyrate-producing bacterium isolated from the caecal content of a broiler chicken. Eeckhaut V; Van Immerseel F; Teirlynck E; Pasmans F; Fievez V; Snauwaert C; Haesebrouck F; Ducatelle R; Louis P; Vandamme P Int J Syst Evol Microbiol; 2008 Dec; 58(Pt 12):2799-802. PubMed ID: 19060061 [TBL] [Abstract][Full Text] [Related]
8. Butyricicoccus pullicaecorum in inflammatory bowel disease. Eeckhaut V; Machiels K; Perrier C; Romero C; Maes S; Flahou B; Steppe M; Haesebrouck F; Sas B; Ducatelle R; Vermeire S; Van Immerseel F Gut; 2013 Dec; 62(12):1745-52. PubMed ID: 23263527 [TBL] [Abstract][Full Text] [Related]
9. Butyrate Producers as Potential Next-Generation Probiotics: Safety Assessment of the Administration of Boesmans L; Valles-Colomer M; Wang J; Eeckhaut V; Falony G; Ducatelle R; Van Immerseel F; Raes J; Verbeke K mSystems; 2018; 3(6):. PubMed ID: 30417112 [TBL] [Abstract][Full Text] [Related]
10. Progress towards butyrate-producing pharmabiotics: Butyricicoccus pullicaecorum capsule and efficacy in TNBS models in comparison with therapeutics. Eeckhaut V; Ducatelle R; Sas B; Vermeire S; Van Immerseel F Gut; 2014 Feb; 63(2):367. PubMed ID: 23766442 [No Abstract] [Full Text] [Related]
12. Isolation and characterisation of new putative probiotic bacteria from human colonic flora. Raz I; Gollop N; Polak-Charcon S; Schwartz B Br J Nutr; 2007 Apr; 97(4):725-34. PubMed ID: 17349085 [TBL] [Abstract][Full Text] [Related]
13. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Louis P; Young P; Holtrop G; Flint HJ Environ Microbiol; 2010 Feb; 12(2):304-14. PubMed ID: 19807780 [TBL] [Abstract][Full Text] [Related]
14. Thiosulfate as a metabolic product: the bacterial fermentation of taurine. Denger K; Laue H; Cook AM Arch Microbiol; 1997 Oct; 168(4):297-301. PubMed ID: 9297467 [TBL] [Abstract][Full Text] [Related]
15. The impact of meals on a probiotic during transit through a model of the human upper gastrointestinal tract. Tompkins TA; Mainville I; Arcand Y Benef Microbes; 2011 Dec; 2(4):295-303. PubMed ID: 22146689 [TBL] [Abstract][Full Text] [Related]
16. A gut butyrate-producing bacterium Chang SC; Shen MH; Liu CY; Pu CM; Hu JM; Huang CJ Oncol Lett; 2020 Dec; 20(6):327. PubMed ID: 33101496 [TBL] [Abstract][Full Text] [Related]
18. Supplementation of Probiotic Wang YC; Ku WC; Liu CY; Cheng YC; Chien CC; Chang KW; Huang CJ Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943506 [TBL] [Abstract][Full Text] [Related]
19. Survival of probiotic lactobacilli in the upper gastrointestinal tract using an in vitro gastric model of digestion. Lo Curto A; Pitino I; Mandalari G; Dainty JR; Faulks RM; John Wickham MS Food Microbiol; 2011 Oct; 28(7):1359-66. PubMed ID: 21839386 [TBL] [Abstract][Full Text] [Related]
20. Methanol utilization by a novel thermophilic homoacetogenic bacterium, Moorella mulderi sp. nov., isolated from a bioreactor. Balk M; Weijma J; Friedrich MW; Stams AJ Arch Microbiol; 2003 May; 179(5):315-20. PubMed ID: 12637975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]